Foghorn Therapeutics

Price & Volume

Stats

Open	$4.96
Previous Close	$5.01
Day Range	$4.96-$5.07
52W Range	$2.94-$9.99
Market Cap	$281.5M
Shares Short	869,228

Financials

Revenue (12 Mos)	$24.1M
Revenue Growth (YoY)	9.7%
Gross Profit (12 Mos)	-$64.4M
Diluted EPS	-$1.14

News

Yahoo Finance • 27 days ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Yahoo Finance • 28 days ago

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

Yahoo Finance • 5 months ago

Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting

Yahoo Finance • 6 months ago

Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting

About

CEO	Mr. Adrian H. B. Gottschalk
Address	500 Technology Square, Cambridge, MA, United States, 02139
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	112